Learn More
Apexbio Technology LLC Orbifloxacin 113617-63-3 50mg

Supplier: Apexbio Technology LLC B180250
Orbifloxacin (CAS 113617-63-3) is a small-molecule inhibitor targeting bacterial DNA gyrase and topoisomerase IV It is designed to inhibit these enzymes thereby impairing bacterial DNA replication and proliferation Orbifloxacin exerts its biological activity primarily through blockade of bacterial DNA gyrase and topoisomerase IV In in vitro studies Orbifloxacin demonstrates broad-spectrum antimicrobial inhibition with an IC50 range of approximately 0 05 0 5 g/mL against various bacterial strains Based on these pharmacological properties Orbifloxacin holds research potential in evaluating bacterial susceptibility profiles and investigating mechanisms underlying bacterial resistance
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.